ETF 及指数产品网格策略周报（2026/2/25）

Core Viewpoint - The article discusses the ETF grid strategy, focusing on specific ETFs that are expected to benefit from upcoming policy changes and market trends, particularly in the consumer and healthcare sectors in Hong Kong [2][3][5]. Group 1: Hong Kong Consumer 50 ETF - The Hong Kong Consumer 50 ETF (159268.SZ) is highlighted as a key focus, with historical data indicating that the period between the Spring Festival and the Two Sessions often leads to market speculation on policy expectations, particularly in the consumer sector [2]. - High-frequency data from the People's Bank of China shows that during the Spring Festival of 2026, transaction volumes reached 393.02 billion transactions, amounting to 13.12 trillion yuan, reflecting a 37.45% increase in transaction volume and a 19.26% increase in transaction value compared to the previous year [2]. - The ETF tracks the National Index of Hong Kong Consumer Theme, with a significant portion of its holdings in "new consumption" sectors such as trendy products and new-style tea drinks, which may exhibit higher elasticity under favorable policy expectations [3]. Group 2: Hong Kong Healthcare ETF - The Hong Kong Healthcare ETF (159366.SZ) has seen increased investment from southbound funds, with net purchases exceeding 150 billion HKD as of February 24, 2026, indicating strong liquidity in the healthcare sector [3]. - Data from the National Medical Products Administration shows that in 2025, the total value of authorized transactions for innovative drugs exceeded 130 billion USD, with over 150 transactions, marking a historical high [5]. - As of February 15, 2026, there have been 39 external authorization transactions for Chinese innovative drugs, with upfront payments totaling approximately 29.53 billion USD, showcasing the significant improvement in China's drug development capabilities [5]. Group 3: Securities and Insurance ETF - The Securities and Insurance ETF (512070.SH) reflects a robust bond issuance environment, with total bond issuance by brokerages reaching 426.04 billion yuan as of February 20, 2026, representing a year-on-year increase of 243.97% [7]. - The approval of bond issuance has reached 322 billion yuan in 2026, providing brokerages with low-cost long-term funding, which enhances their operational capabilities in various capital-intensive businesses [7]. - Recent regulatory measures aimed at optimizing refinancing processes are expected to benefit brokerage firms' investment banking operations, aligning with the policy direction of supporting strong firms while limiting weaker ones [8].